Kohlhof; Hella

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kohlhof; Hella.The latest application filed is for "vidofludimus for use in the treatment or prevention of viral diseases".

Company Profile

3.4.7

Kohlhof; Hella - Munich DE
KOHLHOF; Hella - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vidofludimus for use in the treatment or prevention of viral diseases Grant 11,376,232 - Groppel , et al. July 5, 2	2022-07-05
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation Grant 11,292,788 - Felding , et al. April 5, 2	2022-04-05
Vidofludimus For Use In The Treatment Or Prevention Of Viral Diseases App 20210322351 - GROPPEL; Manfred ; et al.	2021-10-21
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation App 20210061796 - FELDING; Jakob ; et al.	2021-03-04
Novel calcium salt polymorphs as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents App 20210017125 - VITT; Daniel ; et al.	2021-01-21
Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases App 20200360324 - GROPPEL; Manfred ; et al.	2020-11-19
Method of inhibiting DYRK1B Grant 10,633,369 - Aberger , et al.	2020-04-28
Method Of Inhibiting Dyrk1b App 20180201606 - ABERGER; Fritz ; et al.	2018-07-19
Method of inhibiting DYRK1B Grant 9,951,050 - Aberger , et al. April 24, 2	2018-04-24
Gene Expression Biomarkers And Their Use For Diagnostic And Prognostic Application In Patients Potentially In Need Of Hdac Inhibitor Treatment App 20160215348 - KOHLHOF; Hella ; et al.	2016-07-28
Method Of Inhibiting Dyrk1b App 20140371251 - ABERGER; Fritz ; et al.	2014-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.